The BOSS (British Orthopaedic Surgery Surveillance) study: A nationwide service evaluation, and nested-cohort study

There is widespread variation in the management of rare orthopaedic disease, in a large part owing to uncertainty. No individual surgeon or hospital is typically equipped to amass sufficient numbers of cases to draw robust conclusions from the information available to them. The programme of research will establish the BOSS Study; a nationwide reporting structure for rare disease in orthopaedic surgery.

This involved 143 UK hospitals informing the epidemiology and treatment of slipped capital femoral epiphysis (SCFE). This went on to provide the evidence for Big BOSS (recruiting now). The most robust cohort of SCFE published to date.

Finidings published in Bone and Joint.